Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00339950 · ClinicalTrials.gov registry record
Colorectal Neoplasia Screening w Colonoscopy in Asymptomatic Women at Regional Navy/Army Medical Ctrs: The CONCeRN Trial
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 937
- Enrollment target
NCT00339950: Completed study, sponsored by National Cancer Institute (NCI).
NCT00339950 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 937 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00339950 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 937 participants
- Enrollment target
Study Summary
The CONCeRN Trial is a multi-center study of asymptomatic women between the ages of 40 and 75 referred to regional military medical centers for routine colorectal screening. The primary purpose of the main study is to determine the extent to which advanced neoplastic lesions will be missed if clinicians only perform sigmoidoscopies rather than full colonoscopies as a screening procedure and to resolve current debate about the significance of sigmoidoscopic detection of single, small, tubular adenomas (i.e., do they imply greater risk for large adenomatous polyps or colorectal cancer at other sites beyond the reach of the sigmoidoscope, or is there no increased risk?). Women enrolled in the trial receive colonoscopy during which all identified polyps are removed and also during which two pinch biopsies of apparently-normal tissue are taken. In addition, before the colonoscopy is performed, patients wil have blood drawn and answer a brief questionnaire on risk factors for colorectal cancer. The sub-study proposes to add on a more extensive questionnaire to assess dietary and other lifesyle factors potentially related to colorectal cancer, and to draw additional blood for assessment of nutritional status and for analysis of genetic polymorphisms related to colorectal cancer. With the additional information available from these questionnaires and blood samples, it will be possible to explore the extent to which various dietary and genetic risk factors are related to colorectal polyps in asymptomatic women of average risk for disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 937 participants |
| Start Date | 2000-02-14 |
| Est. Completion | 2020-07-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00339950
The ClinicalTrials.gov registry entry for NCT00339950 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 937 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00339950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00339950 about?
NCT00339950 is a clinical study titled "Colorectal Neoplasia Screening w Colonoscopy in Asymptomatic Women at Regional Navy/Army Medical Ctrs: The CONCeRN Trial". The CONCeRN Trial is a multi-center study of asymptomatic women between the ages of 40 and 75 referred to regional military medical centers for routine colorectal screening. The primary purpose of the main study is to determine the extent to which advanced neoplastic lesions will be missed if clinic...
What is the current status of trial NCT00339950?
This trial is currently completed. The enrollment target is 937 participants. The study started on 2000-02-14. Estimated completion is 2020-07-16.
Who is sponsoring clinical trial NCT00339950?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.